Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.
Dr. Hendrik Scholl, a professor of ophthalmology in Wilmer's retina division, contributed an editorial on a recent study on the effectiveness of gene therapy to treat progressive retinal diseases. The results of the study, whick took place at Oxford Eye Hospital in the U.K., were published by Lancet on January 16 and indicated that a group of patients with choroideremia, an inherited retinal disease which leads to blindness by middle age, showed some improvement in vision after receiving a single injection of gene therapy. Dr. Scholl was chosen by Lancet to comment on the study given his expertise in inherited retinal and macular degenerations.
Dr. Scholl was interviewed on Canada's CTV network's morning news program about the positive implications of the study.
Dr. Akrit Sodhi Receives RPB Award - 6/12/2015